Site 0106

Los Angeles, California 90095

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Head and Neck Squamous Cell Carcinoma, Osteosarcoma, Recurrent Head and Neck Squamous Cell Carcinoma

Studies at this site

• FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC — Recruiting now
• A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma — Completed